The Lung Screening, Tobacco and Health Project
Integrating Evidence-Based Smoking Cessation Interventions Into Lung Cancer Screening Programs: A Randomized Trial
Sponsor: Anne Arundel Medical Center
A PHASE3 clinical study on Lung Cancer Screening and Smoking, Tobacco, this trial is completed. The trial is conducted by Anne Arundel Medical Center and has accumulated 14 data snapshots since 2017. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
14 versions recorded-
Sep 2025 — Present [monthly]
Completed PHASE3
-
Sep 2024 — Sep 2025 [monthly]
Completed PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE3
-
Dec 2023 — Jul 2024 [monthly]
Completed PHASE3
Status: Unknown Status → Completed
-
Jul 2023 — Dec 2023 [monthly]
Unknown Status PHASE3
Status: Active Not Recruiting → Unknown Status
▶ Show 9 earlier versions
-
Sep 2021 — Jul 2023 [monthly]
Active Not Recruiting PHASE3
Status: Recruiting → Active Not Recruiting
-
Jan 2021 — Sep 2021 [monthly]
Recruiting PHASE3
-
Feb 2020 — Jan 2021 [monthly]
Recruiting PHASE3
-
Sep 2019 — Feb 2020 [monthly]
Recruiting PHASE3
-
Jul 2019 — Sep 2019 [monthly]
Recruiting PHASE3
-
Sep 2018 — Jul 2019 [monthly]
Recruiting PHASE3
-
Jun 2018 — Sep 2018 [monthly]
Recruiting PHASE3
-
May 2018 — Jun 2018 [monthly]
Recruiting PHASE3
-
Jul 2017 — May 2018 [monthly]
Recruiting PHASE3
First recorded
May 2017
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Anne Arundel Medical Center
- Baptist Health South Florida
- Georgetown University
- Hackensack Meridian Health
- Lahey Hospital & Medical Center
- MedStar Shah Medical Group
- National Cancer Institute (NCI)
- Unity Point Health
- University of Michigan
For direct contact, visit the study record on ClinicalTrials.gov .